Interstitial Lung Disease


Our History

The UT Health San Antonio Interstitial lung disease (ILD) program was founded in 2012 by its current director, Dr. Anoop Nambiar.  In 2015 the program was recognized  by the Pulmonary Fibrosis Foundation (PFF) as a Care Center Network Site, or an ILD Center of Excellence.  This is a distinct honor, received only by 68 centers in the U.S, and 5 in all of Texas.  We serve as the only ILD Center of Excellence for all South Texas.   The program was joined by Dr. Dean “Trey” Kellogg III in 2023.  The program contributes to the three pillars of academic medicine: patient care, research, and education.

Patient Care:

  • Pulmonary Fibrosis Foundation Center of Excellence
  • Comprehensive evaluations and care for a wide array of ILDs, including:
    – Idiopathic Interstitial Pneumonias: IPF
    – Exposure-related: Hypersensitivity pneumonitis
    – Connective tissue disease-associated
    – Sarcoidosis
  • Advanced diagnostic methods
    – Multidisciplinary discussions including pulmonologists, radiologists, pathologists, and rheumatologists
    – ILD-protocol high-resolution CT scan
    – Pulmonary Function Testing
    – Transbronchial cryobiopsy
    – Genomic classifier testing
  • Expedited treatments
    – Immunosuppression
    – Antifibrotics
    – Lung Transplant
    – Pulmonary Rehabilitation
  • Patient-centered care
    – Support Groups

Research

Education

  • Fellowship didactics regarding work of and management of patients with ILD
  • Fellow participation in multidisciplinary ILD conference
  • Hands-on training in the latest diagnostic and therapeutic procedures for ILD
  • Mentorship of students, residents, and fellows interested in ILD